Meta Pixel

News and Announcements

Universal Biosensors Product Update

  • Published April 01, 2016 3:36PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

1st April 2016, ASX Announcement

Universal Biosenors (ASX:UBI) provides below an update to its product development pipeline.

The company has been conducting a review of its current development projects with a view to prioritising development spend and focusing on projects that most enhance shareholder value.

Associated with this review, UBI management have also noted the eligibility criteria to access the R&D cash rebate which is important to UBI’s net cash flow. In particular, it is a condition of the program that the annual revenue remains below $20 million. It makes very little sense for UBI to chase short term small revenue increases that will take our revenue above this limit.

To view the full article please click on the button below.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now